Cargando…

Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare and heterogeneous tumors that present a wide spectrum of different clinical and biological characteristics. Currently, tumor grading, determined by Ki-67 staining and mitotic counts, represents the most reliable predictor of prognosis....

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalcanti, Elisabetta, Galleggiante, Vanessa, Coletta, Sergio, Stasi, Elisa, Chieppa, Marcello, Armentano, Raffaele, Serino, Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379872/
https://www.ncbi.nlm.nih.gov/pubmed/32766159
http://dx.doi.org/10.3389/fonc.2020.01187
_version_ 1783562739472400384
author Cavalcanti, Elisabetta
Galleggiante, Vanessa
Coletta, Sergio
Stasi, Elisa
Chieppa, Marcello
Armentano, Raffaele
Serino, Grazia
author_facet Cavalcanti, Elisabetta
Galleggiante, Vanessa
Coletta, Sergio
Stasi, Elisa
Chieppa, Marcello
Armentano, Raffaele
Serino, Grazia
author_sort Cavalcanti, Elisabetta
collection PubMed
description Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare and heterogeneous tumors that present a wide spectrum of different clinical and biological characteristics. Currently, tumor grading, determined by Ki-67 staining and mitotic counts, represents the most reliable predictor of prognosis. This time-consuming approach fails to reach high reproducibility standards thus requiring novel approaches to support histological evaluation and prognosis. In this study, starting from a microarray analysis of paraffin-embedded tissue specimens, we defined the miRNAs signature for poorly differentiated NETs (G3) compared to well-differentiated NETs (G1 and G2) consisting of 56 deregulated miRNAs. We identified 8 miRNAs that were expressed in all GEP-NETs grades but at different level. Among these miRNAs, miR-96-5p expression level was progressively higher from grade 1 to grade 3; inversely, its target FoxO1 expression decreased from grade 1 to grade 3. Our results reveal that the miRNAs expression profile of GEP-NET is correlated with the tumor grade, showing a potential advantage of miRNA quantification that could aid clinicians in the classification of common GEP-NETs subtypes. These findings could reliably support the histological evaluation of GEP-NETs paving the way toward personalized treatment approaches.
format Online
Article
Text
id pubmed-7379872
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73798722020-08-05 Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades Cavalcanti, Elisabetta Galleggiante, Vanessa Coletta, Sergio Stasi, Elisa Chieppa, Marcello Armentano, Raffaele Serino, Grazia Front Oncol Oncology Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare and heterogeneous tumors that present a wide spectrum of different clinical and biological characteristics. Currently, tumor grading, determined by Ki-67 staining and mitotic counts, represents the most reliable predictor of prognosis. This time-consuming approach fails to reach high reproducibility standards thus requiring novel approaches to support histological evaluation and prognosis. In this study, starting from a microarray analysis of paraffin-embedded tissue specimens, we defined the miRNAs signature for poorly differentiated NETs (G3) compared to well-differentiated NETs (G1 and G2) consisting of 56 deregulated miRNAs. We identified 8 miRNAs that were expressed in all GEP-NETs grades but at different level. Among these miRNAs, miR-96-5p expression level was progressively higher from grade 1 to grade 3; inversely, its target FoxO1 expression decreased from grade 1 to grade 3. Our results reveal that the miRNAs expression profile of GEP-NET is correlated with the tumor grade, showing a potential advantage of miRNA quantification that could aid clinicians in the classification of common GEP-NETs subtypes. These findings could reliably support the histological evaluation of GEP-NETs paving the way toward personalized treatment approaches. Frontiers Media S.A. 2020-07-17 /pmc/articles/PMC7379872/ /pubmed/32766159 http://dx.doi.org/10.3389/fonc.2020.01187 Text en Copyright © 2020 Cavalcanti, Galleggiante, Coletta, Stasi, Chieppa, Armentano and Serino. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Cavalcanti, Elisabetta
Galleggiante, Vanessa
Coletta, Sergio
Stasi, Elisa
Chieppa, Marcello
Armentano, Raffaele
Serino, Grazia
Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades
title Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades
title_full Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades
title_fullStr Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades
title_full_unstemmed Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades
title_short Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades
title_sort altered mirnas expression correlates with gastroenteropancreatic neuroendocrine tumors grades
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379872/
https://www.ncbi.nlm.nih.gov/pubmed/32766159
http://dx.doi.org/10.3389/fonc.2020.01187
work_keys_str_mv AT cavalcantielisabetta alteredmirnasexpressioncorrelateswithgastroenteropancreaticneuroendocrinetumorsgrades
AT galleggiantevanessa alteredmirnasexpressioncorrelateswithgastroenteropancreaticneuroendocrinetumorsgrades
AT colettasergio alteredmirnasexpressioncorrelateswithgastroenteropancreaticneuroendocrinetumorsgrades
AT stasielisa alteredmirnasexpressioncorrelateswithgastroenteropancreaticneuroendocrinetumorsgrades
AT chieppamarcello alteredmirnasexpressioncorrelateswithgastroenteropancreaticneuroendocrinetumorsgrades
AT armentanoraffaele alteredmirnasexpressioncorrelateswithgastroenteropancreaticneuroendocrinetumorsgrades
AT serinograzia alteredmirnasexpressioncorrelateswithgastroenteropancreaticneuroendocrinetumorsgrades